Identification of miR-143-3p as a diagnostic biomarker in gastric cancer

BMC Medical Genomics

Table 5 KEGG pathway enrichment analysis of the selected target genes

KEGG ID	KEGG term	Gene count	p-value
KEGG:05200	Pathways in cancer	24	< 0.001
KEGG:04151	PI3K–Akt signaling pathway	19	< 0.001
KEGG:05205	Proteoglycans in cancer	18	< 0.001
KEGG:05206	MicroRNAs in cancer	17	< 0.001
KEGG:04933	AGE–RAGE signaling pathway in diabetic complications	15	< 0.001
KEGG:05131	Shigellosis	15	< 0.001
KEGG:05161	Hepatitis B	15	< 0.001
KEGG:04510	Focal adhesion	14	< 0.001
KEGG:05417	Lipid and atherosclerosis	14	< 0.001
KEGG:04071	Sphingolipid signaling pathway	13	< 0.001
KEGG:05215	Prostate cancer	13	< 0.001
KEGG:04371	Apelin signaling pathway	12	< 0.001
KEGG:04625	C-type lectin receptor signaling pathway	12	< 0.001
KEGG:04926	Relaxin signaling pathway	12	< 0.001
KEGG:05214	Glioma	12	< 0.001
KEGG:05418	Fluid shear stress and atherosclerosis	12	< 0.001
KEGG:04068	FoxO signaling pathway	11	< 0.001
KEGG:04140	Autophagy	11	< 0.001
KEGG:04210	Apoptosis	11	< 0.001
KEGG:04915	Estrogen signaling pathway	11	< 0.001
KEGG:05218	Melanoma	11	< 0.001
KEGG:04668	TNF signaling pathway	10	< 0.001
KEGG:05145	Toxoplasmosis	10	< 0.001
KEGG:05210	Colorectal cancer	10	< 0.001
KEGG:05220	Chronic myeloid leukemia	9	< 0.001
KEGG:05219	Bladder cancer	7	< 0.001

ISSN: 1755-8794